ACE and metabolic dysfunction-associated steatotic liver disease: Nonetheless, as NAFLD advances to stage 4 (cirrhosis), liver transplantation becomes the primary treatment option, despite the use of multiple medications, such as antibiotics, antivirals, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors, for cirrhosis-associated complications [42].